MedTrace Logo

Adolescence and Diabetes:Can an Automated Closed Loop System Improve Control ?

NCT03300934 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2018-07-31

No results posted yet for this study

Summary

This study evaluates the use of the FD2 automated closed loop insulin administration in Adolescents with a poor metabolic control . All youth will be treated in a random order by their usual pump treatment or an Automated system and we will evaluate whether this has an impact on metabolic control and sleep

Conditions

  • Type1 Diabetes Mellitus

Interventions

DEVICE

closed loop glucose control system

Cross over between Closed loop glucose system with DANA pump, Navigator II CGM and Cambridge AP algorithm FD2A, versus usual CSII pump treatment

Sponsors & Collaborators

  • University of Cambridge

    collaborator OTHER

  • Luxembourg Institute of Health

    collaborator OTHER_GOV

  • Centre Hospitalier du Luxembourg

    lead OTHER

Principal Investigators

  • Carine de Beaufort, MD PhD · Centre Hospitalier du Luxembourg

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
12 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-07-01
Primary Completion
2018-07-19
Completion
2018-07-19

Countries

  • Luxembourg

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03300934 on ClinicalTrials.gov